Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02128087 · ClinicalTrials.gov registry record · NA
Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders
A NA study of Human Immunodeficiency Virus, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 330
- Enrollment target
- 3
- Study locations
NCT02128087 is a NA study of Human Immunodeficiency Virus that has completed, run by RAND. The registered enrollment target is 330 participants, above the 175-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (89% higher). The trial reports 3 study locations across 2 states.
The verdict
NCT02128087, a NA study of Human Immunodeficiency Virus, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
- 3
- Study locations
Study Summary
In this project the investigators develop and test a short message service (SMS) intervention based on the Information Motivation and Behavior skills (IMB) model. Reminding Adolescents To Adhere (RATA) prompts youths at two clinics in Uganda to take their medications and offers social support via weekly text messages. The investigators propose to adapt their previous successful SMS-intervention to the specific needs of youths and to evaluate the relative effectiveness of one-way versus two-way text messages (where two-way messages allow youths to respond to messages and we hypothesize that this may increase perceived social support that may be important for youth populations). We will also test the effectiveness of SMS messages over the longer-term (2 years), for which currently no information is available.
Conditions Studied
Interventions
- BEHAVIORAL Two-way SMS intervention
- BEHAVIORAL One-way SMS intervention group
Study Locations (3)
Other
- Infectious Diseases Institute - Kampala
- Mildmay Uganda - Kampala
California
- RAND - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2013-02 |
| Est. Completion | 2017-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02128087
The ClinicalTrials.gov registry entry for NCT02128087 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 175-participant average among 39 other Human Immunodeficiency Virus trials with a reported enrollment target (89% higher). The listed sponsor is RAND, which has 78 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Human Immunodeficiency Virus appearing as the primary indexed condition, and to 2 interventions - of which Two-way SMS intervention is the first listed.
NCT02128087 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Other, California.
Frequently Asked Questions
What is clinical trial NCT02128087 about?
NCT02128087 is a clinical study titled "Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders". In this project the investigators develop and test a short message service (SMS) intervention based on the Information Motivation and Behavior skills (IMB) model. Reminding Adolescents To Adhere (RATA) prompts youths at two clinics in Uganda to take their medications and offers social support via we...
What is the current status of trial NCT02128087?
This trial is currently completed. It is a NA study. The enrollment target is 330 participants. The study started on 2013-02. Estimated completion is 2017-03-31.
What conditions does trial NCT02128087 study?
This clinical trial studies the following conditions: Human Immunodeficiency Virus.
What interventions are being tested in trial NCT02128087?
The interventions under investigation include: Two-way SMS intervention (BEHAVIORAL), One-way SMS intervention group (BEHAVIORAL).
Who is sponsoring clinical trial NCT02128087?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02128087 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Immunodeficiency Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection
RECRUITING · NA
-
Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities
ACTIVE NOT RECRUITING · NA
-
Integration of Hypertension Management Into HIV Care in Nigeria
ACTIVE NOT RECRUITING · NA
-
Cross-disciplinary HIV Integrated Mental Health Support Intervention
ACTIVE NOT RECRUITING · NA
-
CBSM Intervention Via mHealth to Ameliorate HIV-related Fatigue
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.